Cardiac Safety Study of Brentuximab Vedotin (SGN-35)

Clinical trial NCT01026233 · COMPLETED

Trial details

NCT number: NCT01026233
Sponsor: Seagen Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Disease, Hodgkin Lymphoma, Large-Cell, Anaplastic Lymphoma, Non-Hodgkin

Start date: 2010-01-01
Primary completion: 2010-08-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.